Entities / Company
MaxCyte (United States).
Biotech company in Rockville, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 26
What's happening
Gone quiet
No new reports in 90+ days-
PHC Corporation signed an exclusive agreement with MaxCyte to distribute its platform in Japan, with operations launched in Singapore.Speculative1 report
-
MaxCyte is utilizing LinkedIn for professional following, while Kristen White works for Oak Street Communications.Speculative1 report
-
MaxCyte provided its platform technology to Anocca AB, which will use the technology for manufacturing.Some support1 report
-
TG Therapeutics signed an SPL agreement with MaxCyte on August 7, 2025.Some support1 report
-
MaxCyte (United States) underperformed the market so far this year, based on data from August 7, 2025.Some support1 report
-
MaxCyte licensed its platform technology to Adicet Bio, Inc. for cell therapies, amid reports that Trump-era tariffs benefit AI stocks.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Connections
The 1 strongest of 26, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
SPL Structural
MaxCyte's growth is dependent on the revenue streams and opportunities provided by SPL.
History
Events by the month they beganJune 2026
6 events- PHC Corporation signed an exclusive agreement with MaxCyte to distribute its platform in Japan, with operations launched in Singapore.
- MaxCyte is utilizing LinkedIn for professional following, while Kristen White works for Oak Street Communications.
- MaxCyte provided its platform technology to Anocca AB, which will use the technology for manufacturing.
- TG Therapeutics signed an SPL agreement with MaxCyte on August 7, 2025.
- MaxCyte (United States) underperformed the market so far this year, based on data from August 7, 2025.
- MaxCyte licensed its platform technology to Adicet Bio, Inc. for cell therapies, amid reports that Trump-era tariffs benefit AI stocks.